NuvoResearch.com NuvoResearch.com
Mailing ListMailing ListContactsContactsStock QuoteStock QuoteSite MapSite Map
Transdermal Delivery
Immune Regulation
Home
Company Company
History & Milestones
Executive Team
Subsidiaries
Distribution Partners
Pipeline Pipeline
Transdermal Drug Delivery
Immune Regulation
Technology Technology
MMPE
HTE
Investors Investors
Stock Quote
News Releases
Financial Reports
Webcasts and Presentations
Corporate Governance
Shareholder Information
Info Request
Research Reports
Publications Publications
Transdermal Delivery
Immune Regulation
Technology
Careers Careers
Current Searches

News Releases


News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.

Year: 2008 : 2007 : 2006 : 2005 : 2004


November 16th, 2004

Dimethaid completes $11.2 million financing

November 8th, 2004

Dimethaid Announces Pricing of Unit Financing

November 5th, 2004

Dimethaid Amends Short-term Loan Agreement

October 28th, 2004

Dimethaid Announces Filing of Preliminary Prospectus

October 22nd, 2004

Dimethaid and Solvay Pharma Renew Canadian Pennsaid® Agreement
(en français)

October 13th, 2004

U.S. Medical Journal Publishes Pennsaid Efficacy and Safety Study
(en français)

October 6th, 2004

Dimethaid to Restructure Operations
(en français)

September 30th, 2004

Topical anti-arthritic safer than pills

September 22nd, 2004

Dimethaid appoints new CEO

September 21st, 2004

Dimethaid shareholders elect new board of directors

September 20th, 2004

Dimethaid announces first quarter financial results

September 17th, 2004

Dimethaid waives deadline for deposit of proxies
(en français)

September 15th, 2004

Dimethaid quarterly sales expected to double
(en français)

September 14th, 2004

Dimethaid sets the record straight on dissident circular
(en français)

September 9th, 2004

Fairvest recommends Dimethaid management's slate of directors
(en français)

August 24th, 2004

Dimethaid announces additions to board of directors

August 17th, 2004

Dimethaid announces fourth quarter and fiscal 2004 year-end financial results

August 16th, 2004

Canadian Medical Association Journal publishes Pennsaid results
(en français)

August 10th, 2004

Dimethaid appoints international licensing expert to board of directors
(en français)

July 19th, 2004

FDA approves Penecure antifungal trial
(en français)

July 14th, 2004

Dimethaid reports negative results for Phase III HIV/AIDS study
(en français)

June 24th, 2004

Dimethaid announces filing of final prospectus
(en français)

June 23rd, 2004

Dimethaid comments on financial position
(en français)

June 14th, 2004

Dimethaid announces filing of preliminary prospectus
(en français)

June 10th, 2004

Dimethaid completes private placement financing
(en français)

June 9th, 2004

Dimethaid announces annual meeting date
(en français)

May 21, 2004

Dimethaid announces private placement financing
(en français)

May 20, 2004

Dimethaid board rejects dissident shareholder demands
(en français)

May 11, 2004

Shareholder group requests changes to Dimethaid Directors and CEO
(en français)

May 10, 2004

Dimethaid to move ahead with Phase I/II antifungal clinical trial
(en français)

April 19, 2004

Canadian anti-arthritic lotion headed for Athens Olympics
(en français)

April 7, 2004

Dimethaid announces third quarter financial results
(en français)

March 23, 2004

Dimethaid launches Pennsaid® long-term safety and add-on therapy trials
(en français)

March 8, 2004

In2Focus steps up U.K. Pennsaid® promotion
(en français)

February 23, 2004

Pennsaid® to be distributed in Greece
(en français)

February 11, 2004

Dimethaid and Solvay team up to sell Pennsaid® in Canada
(en français)

February 2, 2004

Dimethaid announces changes to board
(en français)

January 28, 2004

Pennsaid® to be distributed in Portugal
(en français)

January 13, 2004

Dimethaid announces second quarter financial results
(en français)

All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.

Back to top